Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Randomized clinical trial comparing intravitreal aflibercept combined with subthreshold laser to intravitreal aflibercept monotherapy for diabetic macular edema ; volume:12 ; number:1 ; day:23 ; month:6 ; year:2022 ; pages:1-13 ; date:12.2022
Scientific reports ; 12, Heft 1 (23.6.2022), 1-13, 12.2022
- Urheber
-
Tatsumi, Tomoaki
Takatsuna, Yoko
Oshitari, Toshiyuki
Kaiho, Tomomi
Kawasaki, Yohei
Shiko, Yuki
Sugawara, Takeshi
Baba, Takayuki
Yamamoto, Shuichi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-14444-y
- URN
-
urn:nbn:de:101:1-2022081600050741329135
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tatsumi, Tomoaki
- Takatsuna, Yoko
- Oshitari, Toshiyuki
- Kaiho, Tomomi
- Kawasaki, Yohei
- Shiko, Yuki
- Sugawara, Takeshi
- Baba, Takayuki
- Yamamoto, Shuichi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
Full thickness macular hole case after intravitreal aflibercept treatment
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema
Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
Full thickness macular hole case after intravitreal aflibercept treatment
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema
Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema
Intravitreal aflibercept for diabetic macular edema in real-world clinical practice in Japan: 24-month outcomes
Changes in metamorphopsia following intravitreal aflibercept injection for diabetic macular edema
Intravitreal ziv-aflibercept in diabetic vitreous hemorrhage
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
Full thickness macular hole case after intravitreal aflibercept treatment
Result of intravitreal aflibercept injection for myopic choroidal neovascularization
Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema
Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema
Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps
Renal thrombotic microangiopathy and nephrotic proteinuria induced by intravitreal injection of aflibercept for diabetic macular edema